Gv. Papatheodoridis et al., P53 AND BCL-2 PROTEIN EXPRESSION IN RECTOSIGMOID ADENOMAS, The American journal of gastroenterology, 93(7), 1998, pp. 1136-1140
Objective: The aim of this study was to evaluate whether p53 or bcl-2
protein expression in rectosigmoid adenomas is associated with histolo
gical characteristics of the adenomas and with presence of synchronous
advanced proximal neoplasms, Methods: Seventy-six average-risk patien
ts who underwent total colonoscopy and had rectosigmoid adenoma(s) wer
e studied, An adenoma was considered advanced if villous histology and
/or severe dysplasia and/or diameter >1 cm were present, p53 And bcl-2
protein expression was immunohistochemically examined using specific
monoclonal antibodies, Results: p53 Protein was detected in 43 % and b
cl-2 in 93 % of the 76 rectosigmoid adenomas, Advanced compared with n
onadvanced adenomas were significantly more frequently p53-positive (2
8 of 44 or 63.6% vs five of 32 or 15.6%, p < 10(-4)) or had a bcl-2 sc
ore of 12 (20 of 44 or 45.5% vs five of 32 or 15,6%,p = 0.007), Proxim
al advanced neoplasms were mainly found in patients with rectosigmoid
adenomas positive for p53 and with a bcl-2 score of 12 (six of 17 or 3
5.3 % vs 2/59 or 3.4 %, OR: 15.6, p = 0.001) and in particular in thos
e with advanced rectosigmoid adenomas positive for p53 and with a bcl-
2 score of 12 (six of 13 or 46.2 % vs two of 31 or 6.5 %, OR: 12,4, p
= 0,007), Conclusion: p53 Expression and bcl-2 protein overexpression
in rectosigmoid adenomas are associated with advanced histology and a
high risk of synchronous advanced proximal colon neoplasm, (C) 1998 by
Am, Cell, of Gastroenterology.